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Abstract: Unacylated ghrelin (UnGhr) exerts several beneficial actions on vascular function. The
aim of this study was to assess the effects of UnGhr on high-fat induced endothelial dysfunction
and its underlying mechanisms. Thoracic aortas from transgenic mice, which were overexpressing
UnGhr and being control fed either a standard control diet (CD) or a high-fat diet (HFD) for 16 weeks,
were harvested and used for the assessment of vascular reactivity, endothelial nitric oxide synthase
(eNOS) expression and activity, thiobarbituric acid reactive substances (TBARS) and glutathione
levels, and aortic lipid accumulation by Oil Red O staining. Relaxations due to acetylcholine and
to DEA-NONOate were reduced (p < 0.05) in the HFD control aortas compared to vessels from
the CD animals. Overexpression of UnGhr prevented HFD-induced vascular dysfunction, while
eNOS expression and activity were similar in all vessels. HFD-induced vascular oxidative stress
was demonstrated by increased (p < 0.05) aortic TBARS and glutathione in wild type (Wt) mice;
however, this was not seen in UnGhr mice. Moreover, increased (p < 0.05) HFD-induced lipid
accumulation in vessels from Wt mice was prevented by UnGhr overexpression. In conclusion,
chronic UnGhr overexpression results in improved vascular function and reduced plaque formation
through decreased vascular oxidative stress, without affecting the eNOS pathway. This research may
provide new insight into the mechanisms underlying the beneficial effects of UnGhr on the vascular
dysfunction associated with obesity and the metabolic syndrome.
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1. Introduction
Several lines of evidence suggest that ghrelin, a peptide isolated from the stomach with orexigenic
functions, exerts beneficial effects on vascular function and cardiovascular disease [1,2]. In vitro,
ghrelin stimulates nitric oxide (NO) production [3,4] and prevents apoptosis of endothelial cells [5,6].
In vivo, it improves endothelial dysfunction in animal models [7] and in humans [8,9] by nitric
oxide synthase (NOS)-dependent and -independent mechanisms, particularly by stimulating the
release of contractile mediators from the endothelium [10], by antagonizing the effects of systemic
vasoconstrictors such as endothelin 1 [11,12], and by mitigating oxidative stress [8].
Most of the circulating ghrelin exists in the unacylated form (UnGhr), which shares some of
the beneficial effects of ghrelin on the endothelium and on the vascular system [13], as suggested by
clinical studies which have demonstrated an association between low plasma levels of both unacylated
and total ghrelin and early atherosclerosis [14,15]. Although the stimulating effects of unacylated
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ghrelin (UnGhr) on endothelial-dependent vasodilation in isolated arteries from both humans [16]
and experimental animals [17–20] have not been clearly demonstrated, other important properties
on vascular endothelium have been definitively confirmed, mechanistically explaining the protective
role of UnGhr on the vascular system during disease states. Although no specific receptor has yet
been identified, in vitro UnGhr protects endothelial cells from oxidative stress [21,22] and prevents
diabetes-induced endothelial progenitor cell damage by modulating eNOS activity and reactive
oxygen species formation [23]. In addition to the direct beneficial effects on endothelial cells, studies
in experimental models of obesity have shown that unacylated ghrelin counteracts systemic insulin
resistance, oxidative stress, and inflammation, which are typically associated with vascular disease [24].
For these reasons, the administration of unacylated ghrelin has been proposed as a therapeutic tool
for the treatment of obesity-related metabolic and cardiovascular complications [25,26]. Consistent
with these findings, obese subjects with the metabolic syndrome, who are also typically predisposed
to cardiovascular complications, are characterized by a low unacylated to acylated ghrelin ratio [27].
Although the available evidence convincingly suggests that potential benefits of UnGhr on high-fat diet
(HFD)-induced endothelial dysfunction and early vascular disease exist, no information is available
on the impact of UnGhr on endothelial vasorelaxation, eNOS function, vascular oxidative stress and
atherosclerosis burden in the setting of obesity and insulin resistance.
We therefore studied a transgenic mouse model of systemic UnGhr overproduction to test the
hypotheses that UnGhr: (1) positively impacts HFD-induced impaired vasorelaxation by enhancing
eNOS expression/function and/or reducing vascular oxidative stress; (2) lowers the burden of initial
atherosclerotic vascular remodeling in the aortic wall.
2. Results
2.1. Body Weight and Glucose Levels
Body weight was comparable between the groups fed the control diet and the high-fat diet
(Table 1), as previously reported [24]. Blood glucose was also similar during the control diet; in contrast,
after the high-fat diet it increased (p < 0.05) in the wild type but not in the UnGhr group of animals,
as previously published [24] (Table 1).
Table 1. Characteristics of study animals.
Parameter Tg UnGhr Wt
Weight (g)
16-week CD 28.7 ± 2.1 31 ± 2.1
16-week HFD 36.6 ± 1.1 * 37.9 ± 3 *
Blood glucose (mg/dL)
16-week CD 98.2 ± 8 106.0 ± 7.3
16-week HFD 102 ± 11.6 161.9 ± 30.7 *,#
Tg UnGhr: transgenic mice overexpressing unacylated ghrelin; Wt: wild type mice; CD: control diet; HFD: high-fat
diet. * p < 0.05 vs. the same parameter and group on the CD; # p < 0.05 vs. the other group on the HFD. n = 7
animals/group.
2.2. Vascular Reactivity
During the control diet (CD), endothelium-dependent vasodilation was similar within the aortas
from lean wild type and UnGhr-overexpressing animals. As expected, compared with those from lean
animals on the CD, vessels from obese, HFD-fed control mice displayed impaired (p < 0.05) endothelial
vasorelaxation in response to acetylcholine (Figure 1A). In contrast, endothelium-dependent
vasodilation in response to acetylcholine was not impaired in the aortas from obese, HFD-fed
UnGhr-overexpressing animals (Figure 1A). Endothelium-independent vasorelaxation in response
to DEA-NONOate was similar among experimental genotypes during the control diet (Figure 1B).
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During the HFD, impaired (p < 0.05) vasodilation in response to DEA-NONOate in the aortas from
obese wild type mice was normalized by the overexpression of unacylated ghrelin in the transgenic
group under the same experimental conditions (Figure 1B). Contractions in response to phenylephrine
did not differ among groups.
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reactive substances (TBARS) were assessed in plasma and in aortas. Similar concentrations of 
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Figure 1. (A) Concentration-response curves to acetylcholine in wild type (Wt) and transgenic mice
(Tg) overexpressing unacylated ghrelin fed a control (CD) or a high-fat diet (HFD). Vascular reactivity
studies were performed on aortic segments from each group. * p ≤ 0.05 WtHFD vs. WtCD. n = 7
animals/group. Contractions to phenylephrine were similar among the experimental groups. (B)
Concentration-response curves to DEA-NONOate in the same groups. * p ≤ 0.05 vs. WtCD. $ p < 0.05
TgHFD vs. WtHFD. # p < 0.05 TgHFD vs. WtCD. Contractions to phenylephrine were not significantly
different in the four groups. n = 7 animals/group.
2.3. Aortic eNOS Expression and Activity
The eNOS expression was comparable in aortas from wild type and UnGhr-overexpressing
transgenic animals, both under the control and high-fat diet conditions (Figure 2A,B). Accordingly,
eNOS activity was not different between vessels from lean and obese HFD-fed animals from both
genotypes (Figure 2B).
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Figure 2. Protein expression, as detected by Western blot analysis, of the total endothelial nitric oxide
synthase (eNOS) (A) with representative blots (B) and nitric oxide synthase (NOS) activity (C) in aortas
from control (Wt) and transgenic (Tg) mice fed the control diet (CD) or a high-fat diet (HFD). The data
represe t seven mice per group. OD: optical ensity.
2.4. Systemic and Vascular Oxidative Stress and Antioxidant Potential
Since oxidative stress is ssociat d with endothelial dysfunction, levels of thiobarbituric acid
reactive substances (TBARS) were assessed in plasma and in aortas. Similar concentrations of plasma
TBARS were found in the wild type and UnGhr-overexpressing mice, both under the control and
high-fat diets (Figure 3A). Aortic levels of TBARS were not different in vessels from animals belonging
to the two experimental genotypes under the control diet; during the HFD, TBARS levels increased
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(p < 0.05) in aortas from wild type mice, but not in vessels from obese UnGhr animals (Figure 3B).
A similar trend was observed for aortic glutathione (Figure 3C).
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(C) in control (Wt) and transgenic (Tg) mice fed the control diet (CD) or the high-fat diet (HFD). The
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2.5. Early Atherosclerosis Burden in Mouse Aorta
Early atherosclerotic plaque burden was measured in thoracic aortas by quantifying lipid
deposition using Oil Red O staining. During the CD, lean a imals showed similar lipid deposition;
the high-fat diet resulte in increased (p < 0.05) lipid deposition in aortas from wild type mice, which
was prevented by UnGhr overexpression under the same dietary regimen (Figure 4).
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3. Discussion
In this study, we demonstrate that systemic UnGhr upregulation, resulting in sustained levels of
the circulating peptide, prevents high-fat diet-induced vascular dysfunction to endothelium-dependent
and -independent stimuli. This effect is not likely mediated by enhanced eNOS expression and function,
but by reduced vascular oxidative stress, resulting in the prevention of early atherosclerosis and lipid
accumulation in the vascular wall. To the best of the authors’ knowledge, the present study is the
first to examine the effects of unacylated ghrelin on vascular tone and oxidative stress in a transgenic
model of systemic circulating unacylated ghrelin upregulation and high-fat diet-induced obesity.
Previous reports have addressed the issue of the vascular response to unacylated ghrelin in
different species, vascular districts, and disease states. Collectively, the majority of these studies
have shown that unacylated ghrelin evokes endothelium-dependent dilation. Under physiological
conditions, this has been shown in systemic arteries from humans [16], in coronary arteries from
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pigs [18], in systemic vessels from rats [17], and in the cerebral circulation of mice [19]. In this latter
model, however, Ku et al. failed to demonstrate any vasodilator effect of unacylated ghrelin on
the isolated thoracic aorta, as well as on nitric oxide and superoxide production [20]. The apparent
discrepancy between these data and those from our study is likely related to the different metabolic
milieu in the two models. As previously demonstrated [24], the obese UnGhr-overexpressing mice
used in this study were characterized by a better metabolic profile and by lower insulin resistance than
the respective group on the high-fat diet; we suggest that this may have influenced vascular responses
to acetylcholine in the thoracic aortas. In accordance with these findings, it has been previously
demonstrated that obesity and insulin resistance are relevant determinants of vascular function in
humans, playing a far more important role than isolated dysglycemia [28].
In addition, we found that sustained UnGhr overexpression was associated with lower oxidative
stress in the aorta. Indeed, many studies in animal models have shown an effect of unacylated ghrelin
on the redox state [29,30], indicating that in normal conditions the peptide protects vessels from
oxidative stress, both by inducing the expression of endogenous antioxidants [22] and by quenching
the activity of NADPH oxidase [19]. Similar results have been obtained in patients in the setting of
hypertension and diabetes [8,23]. Consistent with the modulatory effect of unacylated ghrelin on
oxidative stress, we found that vessels from transgenic mice were resistant to high-fat diet-induced
oxidative damage, as demonstrated by the lack of an increase of TBARS and of glutathione in this
group. Notably, although blood glucose was lower in HFD-induced obese UnGhr-overexpressing
mice, systemic oxidative stress was unaffected, suggesting that the reduced vascular damage observed
in these conditions is selectively associated with unacylated ghrelin overexpression.
Consistent with the study by Ku et al. [20], who failed to demonstrate UnGhr-stimulated
nitric oxide production of mouse systemic arteries, no evidence was found of any effect of UnGhr
overexpression on eNOS protein levels and activity in mouse thoracic aortas during both the control
and the high-fat diet. The effects of obesity on eNOS expression and activity have been previously
assessed in different experimental models with mixed results [31,32]. In vivo, evidence in humans
shows that obesity-induced endothelial dysfunction is mainly associated with impaired NO production
and eNOS expression [33]. However, severely obese individuals are paradoxically protected by
endothelial dysfunction compared with obese subjects [34]. Therefore, different species, experimental
models, and lengths of exposure to test diets could explain these discrepant results. Further studies
will be necessary to unravel the underlying mechanisms.
Previous in vivo studies in humans have suggested that the combination of both impaired
endothelial-dependent and -independent vasodilation is a stronger predictor of cardiovascular events
than endothelial dysfunction in response to acetylcholine alone [35,36] and that vasodilation in
response to NO donors is a useful marker for the assessment of the degree of atherosclerosis [37].
This observation holds particularly true in the presence of a low degree of atherosclerosis [38].
Consistent with these findings, impaired vasorelaxation in response to both acetylcholine and to
the NO donor DEA-NONOate and higher lipid deposition were detected in aortas from obese mice
belonging to the wild type genotype. In contrast, UnGhr overexpression prevented HFD-induced
endothelium-dependent and -independent dysfunction and lipid accumulation in aortas from
transgenic mice. The evidence from animal studies for the direct involvement of unacylated and
total ghrelin on early plaque development is not equivocal [39,40], while beneficial effects on plaque
stability, via different mechanisms, have been demonstrated for both peptides [41,42]. Collectively,
our findings suggest that the systemic upregulation of unacylated ghrelin is associated with reduced
vascular wall remodeling and early atherosclerosis development in the setting of obesity and insulin
resistance. Although we cannot rule out a direct effect of unacylated ghrelin on plaque development
and progression, we suggest that the beneficial metabolic actions of the peptide could have contributed
to its favorable effects on the vascular system.
Oil Red O (ORO) is commonly used to quantify atherosclerosis in mice [43,44] and the specificity
of this dye for lipids is also demonstrated by its use in advanced modified techniques in several
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settings [45,46]. In this study, ORO staining and the following lipid measurements were performed in
rings from thoracic aortas and not on histological sections. This method was developed and used by
other authors as well [47,48]. In addition, both Andres-Manzano et al. [43] and Lin et al. [44] showed
an excellent agreement between aorta ORO staining and other conventional histopathology techniques
used for atherosclerosis lesion assessment. Although the technique does not allow the precise lipid
composition of the lesions to be defined, it does permit a comparative assessment of the effects of HFD
and UnGhr on plaque development.
In conclusion, unacylated ghrelin demonstrates positive effects on vascular function and early
atherosclerosis development associated with high-fat diet-induced obesity. Underlying mechanisms
include directly reduced vascular oxidative stress and lipid deposition within the aorta and, indirectly,
a favorable metabolic pattern characterized by reduced systemic insulin resistance. Although the
relative contribution of each of these actions to the preservation of vascular function cannot be directly
extrapolated from the current findings, the results of this study provide a rationale for the therapeutic
use of unacylated ghrelin in the treatment of vascular dysfunction and cardiovascular disease in
conditions associated with altered peptide levels, such as obesity and insulin resistance.
4. Material and Methods
4.1. Animal Protocol
The generation and characteristics of transgenic mice overexpressing UnAG (Tg Myh6/Ghrl)
have been described previously [49]. Selective overproduction of ghrelin in the heart, characterized
by negligible acylating activity, results in a 40-fold increment in circulating UnAG without acylated
ghrelin (AG) modification. Experiments were approved by the Institutional Review Board at the
Department of Medicine, University of Piemonte Orientale (Italy). All experiments were conducted
on 14 young adult male Tg Myh6/Ghrl and 14 wild type male mice, matched for age and weight.
Animals underwent 16-week standard or HFD feeding (10% or 60% calories from fat; Research Diets,
New Brunswick, NJ, USA) and were killed as described previously [24]. This study was part of a larger
protocol aimed at assessing the effects of unacylated ghrelin on HFD-induced metabolic alterations,
inflammation, and oxidative stress [24].
4.2. Analytical Methods
4.2.1. Plasma Glucose
Plasma glucose levels were determined by standard colorimetric assay [50].
4.2.2. Plasma and Aortic Oxidative Stress and Antioxidant Potential
Oxidative stress in plasma and aortas was determined by measuring lipid peroxidation (TBARS),
using a commercially available kit (Oxitek, ZeptoMetrix Co., Buffalo, NY, USA) as previously
described [51]. In addition, total glutathione was determined in aortas as referenced [52].
4.2.3. Analysis of Vascular Reactivity
Endothelium-dependent and -independent vasodilation were assessed in organ chambers [53].
Briefly, rings (4 mm long) from thoracic ascending aortas were used for assessing vascular reactivity.
The rings were suspended in organ chambers filled with 25 mL of gassed (95% O2 and 5% CO2)
modified Krebs-Ringer bicarbonate solution (pH 7.4, temperature 37 ◦C; composition in mmol/L: 118.3
NaCl, 4.7 KCl, 2.5 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 25.0 NaHCO3, 0.026 calcium sodium EDTA, and 11.1
glucose). The rings were allowed to equilibrate for 1 h and then were stretched to the optimal point
on the length–tension curve, as determined by repeated exposure to 20 mmol/L KCl. The maximal
contraction of each ring was determined by phenylephrine 10−5 mol· L−1. Submaximal contractions
were obtained using a 10−6 to 10−7 mol·L−1 concentration of phenylephrine. Acetylcholine (10−9
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to 10−5 mol/L) was added cumulatively during a submaximal contraction to phenylephrine.
Concentration responses to DEA-NONOate (10−10 to 10−5 mol·L−1) were similarly performed.
4.3. Assessment of NOS Expression and Activity in the Aorta
Protein levels of eNOS were analyzed by Western blot analysis as previously described [50,51,53].
Aortic segments were isolated and stored in liquid nitrogen. The segments were pulverized and
resuspended in lysis buffer (50 mmol/L Tris HCl, 0.1 mmol/L EDTA, 0.1 mmol/L EGTA, 0.1% SDS,
0.1% deoxycholate, 1% Igepal, 2 µg/mL leupeptin, 2 µg/mL aprotinin, 1 mmol/L PMSF, 1 µg/mL
pepstatin). Aortic debris was homogenized on ice, centrifuged at 14,000 rpm for 10 min, and the
protein concentration was assessed by the bicinchoninic acid protein assay reagent (BCA Protein
Assay, Pierce, Rockford, IL, USA). Protein weighing 20 µg was loaded on 4% stacking/9% separating
SDS/PAGE. The resolved proteins were transferred to a 0.2-µm nitrocellulose membrane on a semi-dry
electrophoretic transfer system (Bio-Rad) for Western blot analysis. Equal protein load was confirmed
by Ponceau staining. Blots were blocked and incubated with an anti-eNOS antibody (1:1000, BD
Transduction Laboratories Franklin Lakes, NJ, USA) overnight at 4 ◦C. After extensive washing,
horseradish peroxidase-linked secondary antibody was added (1:1000, Jackson Laboratories, West
Grove, PA, USA). Chemiluminescence detection was performed with the Western blotting ECL system
(Amersham, Little Chalfont, Buckinghamshire, UK) and exposed to X-ray films. The autoradiographs
were analyzed by densitometry (Model GS-700, Biorad, Hercules, CA, USA). Total NOS activity in
aortas was measured using the oxyhemoglobin to methemoglobin conversion assay as previously
described [51].
4.4. Measurement of Atherosclerotic Burden in Aortas
Quantification of lipid deposition on the surface of aortic arches (fixed for 24 h in 10% formalin)
was determined by Oil Red O (ORO) staining as previously described [48]. The thoracic aortas, cleared
from any perivascular adipose tissue, were incubated with Oil Red O solution (Oil Red O 3% (w/v)
was dissolved in isopropanol at 56 ◦C for 60 min, the solution was then filtered and diluted 2:1 with
ultrapure water) for 30 min at room temperature on a shaker. Samples were then washed by soaking
for 10 s in 70% isopropanol solution, followed by soaking with water. After a 10-min incubation in
chloroform/methanol (2:1 v/v) and the removal of the aortic segments, the absorbance of the solution,
proportional to the amount of lipid in each sample, was determined spectrophotometrically at 520 nm.
The endothelial surface in the sample was measured by a high-resolution scan of the opened and
flattened aortic segments and the relative area was calculated by dedicated software (ImageJ, NIH).
The results were expressed as µg ORO/mm2.
4.5. Statistical Analysis
Statistical analysis was performed with SPSS (version 17, IBM, Armonk, NY, USA). The groups
were compared using a t-test or ANOVA followed by post-hoc tests. Benjamini–Hochberg correction
for multiple comparisons was applied. Quantitative data are presented as means ± S.E.M. A p-value
< 0.05 was considered statistically significant.
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